ENI: Clinical Trials

2 trials of ENI, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 2

Follow ENI: new trials by email Literature Review of ENI trials Research Report on ENI

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunotherapy and Nodal-Sparing Irradiation for T-Cell Induction and Unmasking of Tumor Antigenicity in the Microenvironment for Head and Neck Cancer
Pembrolizumab, Radiotherapy, ENI - Head and Neck Cancer Squamous Cell Carcinoma
Phase 2RecruitingMedical College of Wisconsin202026-10-082026-10-19
Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy
ENI using IMRT with or without chemotherapy, INRT, ENI - Head and Neck Cancer
Phase 2RecruitingUniversity of Texas Southwestern Medical Center802024-11-142026-04-17

Conditions studied

Head and Neck Neoplasms (1)

Sponsors

Medical College of Wisconsin (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

United States (2)

Top investigators

David Sher, MD (1)  ·  Musaddiq Awan, MD (1)

Results publications

PMID 42116021

NIH funding

R01CA251792 (1)